Thermo Fisher Scientific INC Form 4 insider transactions

Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific, disposed of shares to cover tax obligations arising from equity awards.

Thermo Fisher Scientific's CEO, Marc Casper, reported the disposal of common stock to cover tax obligations arising from equity awards.

Lisa P. Britt, a Senior VP and Chief HR Officer at Thermo Fisher Scientific, reported disposing of common stock to cover tax obligations arising from equity awards.

Michael A. Boxer, SVP and General Counsel of Thermo Fisher Scientific, disposed of shares to cover tax obligations arising from equity awards.

Executive Vice President Gianluca Pettiti of Thermo Fisher Scientific reported the disposal of common stock to cover tax obligations.

Stephen Williamson, CFO of Thermo Fisher Scientific, reported the disposal of 406.141 shares of common stock on August 23, 2024.

Michael D. Shafer, Executive Vice President of Thermo Fisher Scientific, reports a disposition of common stock to cover tax obligations.

Frederick M. Lowery, Executive Vice President of Thermo Fisher Scientific, reports changes in beneficial ownership of company stock, including acquisitions and disposals.

Executive Vice President and COO of Thermo Fisher Scientific, Michel Lagarde, reports the disposal of 504.29 shares of common stock on August 23, 2024.

Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific, reported the disposal of common stock on August 23, 2024.

Thermo Fisher Scientific's CEO, Marc Casper, reported a transaction involving the disposal of common stock to cover tax obligations, while also detailing indirect ownership through various trusts and entities.

Lisa P. Britt, Sr. VP and Chief HR Officer of Thermo Fisher Scientific, reported a disposition of common stock to cover tax obligations.

Michael A. Boxer, SVP and General Counsel of Thermo Fisher Scientific, disposed of 145.05 shares of common stock on August 23, 2024, to cover tax obligations.

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares on July 31, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares of common stock on July 29 and 30, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Gianluca Pettiti, Executive Vice President of Thermo Fisher Scientific, sold 300 shares of common stock at $600.85 per share on July 26, 2024, according to a Form 4 filing.

Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific, executed stock options and sold shares on July 26, 2024.

Lisa P. Britt, Sr. VP and Chief HR Officer of Thermo Fisher Scientific, recently sold shares of the company's common stock.

Thermo Fisher Scientific's SVP and General Counsel, Michael A. Boxer, exercised stock options and sold shares on July 26, 2024, according to a Form 4 filing with the SEC.

Director Scott M. Sperling reports acquisition of phantom stock units in Thermo Fisher Scientific's Deferred Compensation Plan for Directors.

Director R. Alexandra Keith reports acquisition of phantom stock units in Thermo Fisher Scientific through a deferred compensation plan.

Director Dion J. Weisler reports acquisition of phantom stock units in Thermo Fisher Scientific's Deferred Compensation Plan for Directors.

Director Jennifer M. Johnson reports acquisition of phantom stock units in Thermo Fisher Scientific Inc. under the Deferred Compensation Plan for Directors.

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Stephen Williamson, CFO of Thermo Fisher Scientific, reported the disposal of 1,112 shares of common stock on May 28, 2024.

Director Lars Rebien Sorensen reported a transaction involving Thermo Fisher Scientific Inc. common stock on May 22, 2024.

Director Ruby R. Chandy reports acquisition and disposal of Thermo Fisher Scientific common stock on May 22, 2024.

Director C. Martin Harris of Thermo Fisher Scientific reported the acquisition and disposal of common stock on May 22, 2024.

Director Nelson Chai reports acquiring and disposing of Thermo Fisher Scientific common stock on May 22, 2024.

Director Jennifer M. Johnson reported acquiring 339 shares of Thermo Fisher Scientific Inc. common stock on May 22, 2024.